+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Omics"

Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Viral Vector Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 250 Pages
  • Global
From
Precision Medicine Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Precision Medicine Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 650 Pages
  • Global
From
Cell Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cell Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 500 Pages
  • Global
From
From
Genomic Collaboration and Licensing Deals 2018-2024 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
Loading Indicator

Omics is a term used to describe the study of biological molecules, such as proteins, nucleic acids, and metabolites. It is a rapidly growing field of biotechnology that is used to understand the complex interactions between genes, proteins, and other molecules in living organisms. Omics technologies are used to identify and characterize the components of biological systems, and to study their interactions and functions. This information can be used to develop new treatments for diseases, improve crop yields, and create new products. Omics technologies are used in a variety of industries, including pharmaceuticals, agriculture, and food and beverage. Companies in the Omics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more